Ipilimumab/sintilimabAsthma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1890卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09140-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：143 / 143

相关论文

共 50 条

[1] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2022, 1887 (1) : 396 - 396
[2] Ipilimumab/nivolumabMyocarditis: case report
[J]. Reactions Weekly, 2021, 1854 (1) : 199 - 199
[3] Ipilimumab/pembrolizumabIleus: case report
[J]. Reactions Weekly, 2023, 1956 (1) : 287 - 287
[4] Ipilimumab/nivolumabHepatitis: case report
[J]. Reactions Weekly, 2019, 1734 (1) : 292 - 292
[5] Ipilimumab/sargramostimDermatomyositis: case report
[J]. Reactions Weekly, 2016, 1603 (1) : 158 - 158
[6] Ipilimumab/nivolumabHypopituitarism : case report
[J]. Reactions Weekly, 2022, 1907 (1) : 267 - 267
[7] Ipilimumab/nivolumabPancreatitis: case report
[J]. Reactions Weekly, 2022, 1924 (1) : 259 - 259
[8] Ipilimumab/pembrolizumabHypophysitis: case report
[J]. Reactions Weekly, 2022, 1909 (1) : 306 - 306
[9] Ipilimumab/nivolumabVitiligo: case report
[J]. Reactions Weekly, 2019, 1769 (1) : 262 - 262
[10] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2019, 1747 (1) : 159 - 159

← 1 2 3 4 5 →